These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 4733)

  • 1. Huntington's chorea. Changes in neurotransmitter receptors in the brain.
    Enna SJ; Bird ED; Bennett JP; Bylund DB; Yamamura HI; Iversen LL; Snyder SH
    N Engl J Med; 1976 Jun; 294(24):1305-9. PubMed ID: 4733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurochemical findings in Huntington's chorea.
    Bird ED; Iversen LL
    Essays Neurochem Neuropharmacol; 1977; 1():177-95. PubMed ID: 152197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of brain neurotransmitter receptor binding in Huntington's chorea.
    Enna SJ; Bennett JP; Bylund DB; Snyder SH; Bird ED; Iversen LL
    Brain Res; 1976 Nov; 116(3):531-7. PubMed ID: 10053
    [No Abstract]   [Full Text] [Related]  

  • 4. [Huntington chorea. Review of the most recent aspects of research].
    Albano C; Farinini D; Tassinari T; Caponnetto C; Bacigalupo F
    Riv Neurol; 1985; 55(4):247-55. PubMed ID: 2997905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotransmitter receptor alterations in Huntington's disease: autoradiographic and homogenate studies with special reference to benzodiazepine receptor complexes.
    Whitehouse PJ; Trifiletti RR; Jones BE; Folstein S; Price DL; Snyder SH; Kuhar MJ
    Ann Neurol; 1985 Aug; 18(2):202-10. PubMed ID: 2994554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-adrenergic receptor subtypes in the basal ganglia of patients with Huntington's chorea and Parkinson's disease.
    Waeber C; Rigo M; Chinaglia G; Probst A; Palacios JM
    Synapse; 1991 Aug; 8(4):270-80. PubMed ID: 1656540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excitatory amino acid binding sites in the caudate nucleus and frontal cortex of Huntington's disease.
    Dure LS; Young AB; Penney JB
    Ann Neurol; 1991 Dec; 30(6):785-93. PubMed ID: 1665055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
    Huot P; Lévesque M; Parent A
    Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurochemical alterations in Huntington's chorea: a study of post-mortem brain tissue.
    Spokes EG
    Brain; 1980 Mar; 103(1):179-210. PubMed ID: 6102490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dementia in Huntington's disease is associated with neurochemical deficits in the caudate nucleus, not the cerebral cortex.
    Reynolds GP; Pearson SJ; Heathfield KW
    Neurosci Lett; 1990 May; 113(1):95-100. PubMed ID: 1973277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in understanding Huntington's chorea.
    Barbeau A
    Can J Neurol Sci; 1975 May; 2(2):81-5. PubMed ID: 124199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neurotransmitters in Huntington chorea (review)].
    Barkhatova VP; Larskiĭ EG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(3):444-50. PubMed ID: 2581405
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma choline and cholinergic mechanisms in the brain. Methods, function, and rôle in Huntington's chorea.
    Eckernäs SA
    Acta Physiol Scand Suppl; 1977; 449():1-62. PubMed ID: 143869
    [No Abstract]   [Full Text] [Related]  

  • 14. Biochemical changes in Alzheimer's disease-senile dementia: neurotransmitters in senile dementia of the Alzheimer's type.
    Davies P
    Res Publ Assoc Res Nerv Ment Dis; 1979; 57():153-66. PubMed ID: 33427
    [No Abstract]   [Full Text] [Related]  

  • 15. Enzymes associated with the metabolism of catecholamines, acetylcholine and gaba in human controls and patients with Parkinson's disease and Huntington's chorea.
    McGeer PL; McGeer EG
    J Neurochem; 1976 Jan; 26(1):65-76. PubMed ID: 3629
    [No Abstract]   [Full Text] [Related]  

  • 16. [Neuropharmacologic approach in Huntington's chorea].
    Agid Y
    Rev Neurol (Paris); 1975 Dec; 131(12):847-65. PubMed ID: 134438
    [No Abstract]   [Full Text] [Related]  

  • 17. Alterations in brain muscarinic cholinergic receptor binding and choline acetyltransferase activity in Huntington's disease.
    Wastek GJ; Johnson PC; Stern LZ; Yamamura HI
    Proc West Pharmacol Soc; 1976; 19():170-1. PubMed ID: 136659
    [No Abstract]   [Full Text] [Related]  

  • 18. Loss of striatal histamine H2 receptors in Huntington's chorea but not in Parkinson's disease: comparison with animal models.
    Martínez-Mir MI; Pollard H; Moreau J; Traiffort E; Ruat M; Schwartz JC; Palacios JM
    Synapse; 1993 Nov; 15(3):209-20. PubMed ID: 7904088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased receptor-binding sites for kainic acid in brains of patients with Huntington's disease.
    London ED; Yamamura HI; Bird ED; Coyle JT
    Biol Psychiatry; 1981 Feb; 16(2):155-62. PubMed ID: 6452910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurobiology and pharmacology of Huntington's disease.
    Enna SJ
    Life Sci; 1977 Jan; 20(2):205-11. PubMed ID: 190505
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.